Find clinical trials for Acute Myeloid Leukemia (AML) in San Diego, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near San Diego, CA, USA:
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
La Jolla, California, United States of America and 33 other locations
Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs,...
Phase 1
La Jolla, California, United States and 3 other locations
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
La Jolla, California, United States and 56 other locations
This is a Phase 1/2a, multicenter, open-label, first-in-human (FIH) study of VOR33 in participants with AML or MDS who are undergoing human ...
Phase 1, Phase 2
La Jolla, California, United States and 13 other locations
T cell therapy (VCAR33) in patients with relapsed or refractory Acute Myeloid Leukemia (AML) after human leukocyt...
Phase 1, Phase 2
La Jolla, California, United States and 12 other locations
This trial evaluates how well CPX-351 and enasidenib work in treating patients with acute myeloid leukemia characterized b...
Phase 2
San Diego, California, United States and 2 other locations
drugs in treating pediatric and young adult patients with acute myeloid leukemia (AML) or acute leukemia...
Phase 1
San Diego, California, United States and 10 other locations
be tolerable and active in pediatric patients with newly diagnosed acute myeloid leukemia (AML).Primary Objective...
Phase 2
San Diego, California, United States and 4 other locations
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azaci...
Phase 1
La Jolla, California, United States and 27 other locations
Study CC-91633-AML-001 is a Phase 1, open-label, dose escalation and expansion, first-in-human (FIH) clinical study of CC-91633 (BMS-986397) ...
Phase 1
La Jolla, California, United States and 28 other locations
Clinical trials
Research sites
Resources
Legal